- Home
- FCBC vs ORGO Comparison
FCBC vs ORGO Comparison
Compare FCBC & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCBC
- ORGO
- Stock Information
- Founded
- FCBC 1874
- ORGO 1985
- Country
- FCBC United States
- ORGO United States
- Employees
- FCBC N/A
- ORGO N/A
- Industry
- FCBC Major Banks
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- FCBC Finance
- ORGO Health Care
- Exchange
- FCBC Nasdaq
- ORGO Nasdaq
- Market Cap
- FCBC 696.3M
- ORGO 620.3M
- IPO Year
- FCBC 1992
- ORGO N/A
- Fundamental
- Price
- FCBC $37.56
- ORGO $5.00
- Analyst Decision
- FCBC
- ORGO Buy
- Analyst Count
- FCBC 0
- ORGO 2
- Target Price
- FCBC N/A
- ORGO $7.50
- AVG Volume (30 Days)
- FCBC 39.4K
- ORGO 724.8K
- Earning Date
- FCBC 10-21-2025
- ORGO 08-07-2025
- Dividend Yield
- FCBC 3.30%
- ORGO N/A
- EPS Growth
- FCBC N/A
- ORGO N/A
- EPS
- FCBC 2.72
- ORGO N/A
- Revenue
- FCBC $162,762,000.00
- ORGO $429,531,000.00
- Revenue This Year
- FCBC $2.27
- ORGO $2.57
- Revenue Next Year
- FCBC $11.13
- ORGO $9.80
- P/E Ratio
- FCBC $13.79
- ORGO N/A
- Revenue Growth
- FCBC N/A
- ORGO N/A
- 52 Week Low
- FCBC $32.81
- ORGO $2.46
- 52 Week High
- FCBC $49.02
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- FCBC 50.34
- ORGO 57.40
- Support Level
- FCBC $37.00
- ORGO $4.90
- Resistance Level
- FCBC $40.49
- ORGO $5.14
- Average True Range (ATR)
- FCBC 1.45
- ORGO 0.23
- MACD
- FCBC 0.16
- ORGO 0.01
- Stochastic Oscillator
- FCBC 61.85
- ORGO 75.16
About FCBC First Community Bankshares Inc. (VA)
First Community Bankshares Inc is a financial holding company that provides commercial banking products and services. The company is engaged in providing demand deposit accounts, savings, and money market accounts, certificates of deposits; commercial, consumer, and real estate mortgage loans, and lines of credit; various credit card, debit card, and automated teller machine card services; corporate and personal trust services; investment management services and life, health, and property and casualty insurance products. The company's revenue is mainly derived from interest, fees, and commissions.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.